Search

Filter by

Document type
Last updated
First published

Search results (25902)


The European Medicines Agency (EMA) is exploring an improved approach for biosimilar medicine development and evaluation, while upholding strict European Union (EU) safety standards. The is outlined in a draft reflection paper biosimilar development. Its aim is to reduce the amount of clinical data required for the development and approval of...

HumanScientific guidelines
MedicineHumanAuthorised
MedicineHumanAuthorised
MedicineHumanAuthorised
MedicineHumanAuthorised
MedicineHumanAuthorised
MedicineHumanAuthorised
MedicineHumanAuthorised
MedicineHumanAuthorised